The first gene-silencing drug wins FDA approval

Using RNA interference, patisiran prevents symptoms by blocking DNA instructions

illustration of RNA

INTERCEPTION  Small bits of RNA can latch onto longer messenger RNA molecules that are carrying DNA’s instructions to make proteins (illustrated), halting the production process. A newly approved drug uses this natural process to turn off a specific gene.

BSIP SA/Alamy 

This article is only available to Science News subscribers.

Subscribers, enter your e-mail address to access our archives.

Not a subscriber?

Science News is a nonprofit.

Support us by subscribing now.

More Stories from Science News on Health & Medicine

From the Nature Index

Paid Content